Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis

Tatsuji Mino, Yuta Katayama, MD PhD, Tatsuya Terasaki, MD, Yu Kochi, MD, Fumiaki Jinnouchi, MD, Takeshi Okatani, MD, Ryota Imanaka, MD, Kohei Kyo, MD, Mitsuhiro Itagaki, MD, Shinya Katsutani, MD PhD, Tsuyoshi Muta, MD, Koji Iwato, MD PhD, Hideki Asaoku, MD

Blood (2018) 132 (Supplement 1): 2095.

https://doi.org/10.1182/blood-2018-99-113461

Published: 2018

Journal Articles

Suboptimal Engraftment Is Associated with Reduced Exposure to Fludarabine Metabolite in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation

Caroline Bateman, MBBS, PhD MRCP, FRCPath, Christa Nath, BSC (Hons), PhD, Melissa Gabriel, MBBS, FRACP, Steven Keogh, MBBS (Hons), FRACP, Samiuela Lee, PhD, Peter J Shaw

Blood (2016) 128 (22): 2189.

https://doi.org/10.1182/blood.V128.22.2189.2189

Published: 2016

Journal Articles

BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal – Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.

Manoj Kumar Kashyap, PhD, Deepak Kumar, PhD, Harrison Jones Jones, BS, Michael Y. Choi, MD, Johanna Melo-Cardenas, B.Sc, Michelle R. Kuhne, PhD, Peter Sabbatini, PhD, Lewis Cohen, MD, MS, Suresh Shelat, MD-PhD, Pina M Cardarelli, Ph.D., Thomas J. Kipps, MD, PhD, Januario E. Castro, M.D.

Blood (2012) 120 (21): 2887.

https://doi.org/10.1182/blood.V120.21.2887.2887

Published: 2012

Journal Articles

An Interim Evaluation of Systemic F-Ara-a Exposure in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients Using An Optimal Sampling Design

Janel R Long-Boyle, PharmD, PhD, Shirley Yan, BS, Christopher C. Dvorak, MD, Biljana N. Horn, MD, Morton Jerome Cowan, MD, Liusheng Huang, PhD, Nancy Sambol, PharmD, Lisa Musick, PharmD, Francesca Aweeka, PharmD

Blood (2011) 118 (21): 1962.

https://doi.org/10.1182/blood.V118.21.1962.1962

Published: 2011

Journal Articles

Possible Two Different Mechanisms of Engraftment Failure in Cord Blood Transplantation: Graft Rejection and Poor Graft Function

Hikari Ota, MD, Kazuhiro Masuoka, MD, Naoyuki Uchida, MD, PhD, Izumi Kaihori, Yuki Taya, MD, Aya Nishida, MD, Taichi Ikebe, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Yuki Asano-Mori, MD, PhD, Koji Izutsu, MD, PhD, Naofumi Matsuno, MD, PhD, Atsushi Wake, MD, PhD, Akiko Yoneyama, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2011) 118 (21): 651.

https://doi.org/10.1182/blood.V118.21.651.651

Published: 2011

Journal Articles

Single Cell Profiling of B Cell Receptor Signaling and Apoptosis Networks in Chronic Lymphocytic Leukemia: Association with in Vitro Sensitivity to Fludarabine Monophosphate (F-ara-A).

Erik Evensen, PhD, Adam Palazzo, Ying-Wen Huang, MS, Alessandra Cesano, MD, PhD, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD, PhD, Wendy J. Fantl, PhD

Blood (2009) 114 (22): 1263.

https://doi.org/10.1182/blood.V114.22.1263.1263

Published: 2009

Journal Articles

Pre-Transplant Conditioning Using Intravenous Busulfan Is a Feasible and Effective Option in Reduced-Intensity Cord Blood Transplantation.

Naoyuki Uchida, MD, Hisashi Yamamoto, MD, Naofumi Matsuno, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Shinsuke Takagi, MD, Hideki Araoka, MD, Daisuke Kato, MD, Mayumi Yoshimi, MD, Sachiko Seo, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Madoka Narita, Kimiko Sagawa, Akiko Yoneyama, MD, Shigeyoshi Makino, MD, Shuichi Taniguchi, MD, PhD

Blood (2008) 112 (11): 3273.

https://doi.org/10.1182/blood.V112.11.3273.3273

Published: 2008

Journal Articles

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

Sanne H. Tonino, MD, Chantal Mulkens, Yoshinori Nonomura, MD, Guangli Suo, MD, Thomas J. Kipps, MD, PhD, Marinus H.J. van Oers, MD, PhD, Eric Eldering, MD, Arnon P. Kater, MD, PhD

Blood (2008) 112 (11): 2102.

https://doi.org/10.1182/blood.V112.11.2102.2102

Published: 2008

Journal Articles

TPLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.

Georg Hopfinger, MD, Raymonde Busch, PD, Eichhorst Barbara, MD, Cramer Paula, MD, Kandler Gabriele, MD, Fingerle-Rowson Gunther, MD, Fink Anna-Maria, MD, Stilgenbauer Stephan, MD, Hallek Michael, MD

Blood (2007) 110 (11): 2039.

https://doi.org/10.1182/blood.V110.11.2039.2039

Published: 2007

Journal Articles

In Vitro Toxicity of Fludarabine on Normal Bone Marrow (BM) Progenitors Suggests Its Involvement in the Impairment of Hematopoietic Progenitor (HP) Mobilization.

Céline Richard, PhD, Véronique Maguer-Satta, PhD, Juliette Berger, Sandrine Jeanpierre, Franck E. Nicolini, MD, PhD, Olivier Tournilhac, MD, PhD, Mauricette Michallet, MD, PhD, Marc G. Berger, MD, PhD

Blood (2007) 110 (11): 1192.

https://doi.org/10.1182/blood.V110.11.1192.1192

Published: 2007

Journal Articles

Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells.

Amel B. Bouzar, PhD, Mathieu Boxus, MS, Julien Defoiche, MS, Hervé Balon Techn, Guy Berchem, PhD, Derek Macallan, PhD, Ruth Pettengel, PhD, Fenella Willis, PhD, Arsene Burny, PhD, Laurence Lagneaux, PhD, Dominique Bron, PhD, Bernard Chatelain, PhD, Christian Chatelain, PhD, Luc Willems, PhD

Blood (2007) 110 (11): 4712.

https://doi.org/10.1182/blood.V110.11.4712.4712

Published: 2007

Journal Articles

Acute Adult Leukemia (ATL) Successfully Treated with Full Matched Sibling Bone Marrow Transplantation and Haplo-Identical (3 Locus Mis-Matched) Peripheral Stem Cell Transplantation.

Mitsuru Koike, MD, Yohsinori Suzuki, MD, Yasuyuki Inoue, MD, Takao Suzuki, MD, Kouhei Ogawa, MD, Shigesaburo Miyakoshi, MD, Masayuki Kato, MD, Masatomo Takahashi, MD, Ikuo Miura, MD

Blood (2006) 108 (11): 5412.

https://doi.org/10.1182/blood.V108.11.5412.5412

Published: 2006

Journal Articles

Economics of Intravenous Fludarabine Phosphate and Oral Fludarabine Phosphate for the Treatment of B-Cell Chronic Lymphocytic Leukemia in a Developing Country - Brazil.

Ricardo Bigni, MD, Gabriela T.B. Araújo, Bsc;MBA, Marcelo C.M. Fonseca, MD;MBA, Jane Dubin, MD, Arthur M. Coelho, MD, Reinaldo Dal Bello, MD

Blood (2006) 108 (11): 5498.

https://doi.org/10.1182/blood.V108.11.5498.5498

Published: 2006

Journal Articles

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Teruhiko Kozuka, MD, Kazushi Tanimoto, MD, Koichi Nakase, MD, Yuichiro Nawa, MD, Masamichi Hara, MD

Blood (2006) 108 (11): 5384.

https://doi.org/10.1182/blood.V108.11.5384.5384

Published: 2006

Journal Articles

Fludarabine Monophosphate in Indolent Non Hodgkin’s Lymphoma (NHL) - Clinical Experience (1995–2006).

J.E. Novoa, MD, B. Beñaran, MD, A.L. Rojo, MD, R. Draper, MD, H. Calvo, MD, N. Iriondo, MD, L. Diaz, MD, M. Rivero, MD, J. Segura, MD, P. Segura, MD, A. Sosa, MD, S. Brignoni, MD, A. Luongo, MD, R. De Bellis, MD

Blood (2006) 108 (11): 4664.

https://doi.org/10.1182/blood.V108.11.4664.4664

Published: 2006

Journal Articles

An International Multicentric Trial with Fludarabine Plus Cyclosphosphamide in B-Cell Chronic Lymphocytic Leukemia (CLL) “Up Front”: Second Interim Analysis.

Fernando Bezares, MD, Cecilio Jait, MD, Daniel Caviglia, MD, Daniel Bhar, MD, Andrea Rodriguez, MD, Norma Pilnik, MD, Virginia Prates, MD, Francisco Lastiri, MD, D. del Carpio, MD, Antonio A. Carrasco-Yalan, MD, Sergio Giralt, MD

Blood (2006) 108 (11): 4969.

https://doi.org/10.1182/blood.V108.11.4969.4969

Published: 2006

Journal Articles

Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience.

J.E. Novoa, MD, A.L. Rojo, MD, B. Beñaran, MD, R. Draper, MD, H. Calvo, MD, N. Iriondo, MD, L. Diaz, MD, M. Rivero, MD, A. Cabrera, MD, M. Pebet, MD, S. Brignoni, MD, A. Luongo, MD, R. De Bellis, MD

Blood (2006) 108 (11): 4970.

https://doi.org/10.1182/blood.V108.11.4970.4970

Published: 2006

Journal Articles

Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL.

Jean-Francois Rossi, A. Van Hoof, K. De Boeck, S. A. Johnson, D. Bron, C. Foussard, T. A. Lister, M. H.H. Kramer, T. J. Littlewood, R. E. Marcus, E. Deconinck, O. Guibon, M. Montillo, S. M. Tollerfield

Blood (2005) 106 (11): 2128.

https://doi.org/10.1182/blood.V106.11.2128.2128

Published: 2005

Journal Articles

T-PLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.

Georg Hopfinger, MD, Raymonde Busch, PD, Barbara Eichhorst, MD, Gabriele Kandler, MD, Clemens Wendtner, MD, Michael Hallek, MD

Blood (2005) 106 (11): 2130.

https://doi.org/10.1182/blood.V106.11.2130.2130

Published: 2005

Journal Articles

High Risk Hairy Cell Leukemia (HCL) Treatment with Fludarabine: Report of Three Cases with Low Toxicity and Durable Responses.

Antonio A. Carrasco-Yalan, MD, Olga M. López-Odría, MD, Luis Riva-Gonzales, MD, Pilar Quiñones-Avila, MD, Fernando Cauvi-R, MD, Sergio A. Murillo-Vizcarra, MD, Jorge S. Valdés-Gómez, MD, Julia Huamaní-Zavala, PharmD, Jorge A. Castillo-Aguirre, MD, Brady E. Beltrán-Gárate, MD

Blood (2005) 106 (11): 4769.

https://doi.org/10.1182/blood.V106.11.4769.4769

Published: 2005

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis

Suboptimal Engraftment Is Associated with Reduced Exposure to Fludarabine Metabolite in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation

BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal – Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.

An Interim Evaluation of Systemic F-Ara-a Exposure in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients Using An Optimal Sampling Design

Possible Two Different Mechanisms of Engraftment Failure in Cord Blood Transplantation: Graft Rejection and Poor Graft Function

Single Cell Profiling of B Cell Receptor Signaling and Apoptosis Networks in Chronic Lymphocytic Leukemia: Association with in Vitro Sensitivity to Fludarabine Monophosphate (F-ara-A).

Pre-Transplant Conditioning Using Intravenous Busulfan Is a Feasible and Effective Option in Reduced-Intensity Cord Blood Transplantation.

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

TPLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.

In Vitro Toxicity of Fludarabine on Normal Bone Marrow (BM) Progenitors Suggests Its Involvement in the Impairment of Hematopoietic Progenitor (HP) Mobilization.

Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells.

Acute Adult Leukemia (ATL) Successfully Treated with Full Matched Sibling Bone Marrow Transplantation and Haplo-Identical (3 Locus Mis-Matched) Peripheral Stem Cell Transplantation.

Economics of Intravenous Fludarabine Phosphate and Oral Fludarabine Phosphate for the Treatment of B-Cell Chronic Lymphocytic Leukemia in a Developing Country - Brazil.

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Fludarabine Monophosphate in Indolent Non Hodgkin’s Lymphoma (NHL) - Clinical Experience (1995–2006).

An International Multicentric Trial with Fludarabine Plus Cyclosphosphamide in B-Cell Chronic Lymphocytic Leukemia (CLL) “Up Front”: Second Interim Analysis.

Fludarabine Monophosphate as First Line Therapy for Chronic Lymphocytic Leukemia (CLL) - 11 Years Clinical Experience.

Follow-Up Results of a Prospective, Multicenter, Open-Label Study of Oral Fludarabine Phosphate in Patients with Previously Untreated B-CLL.

T-PLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.

High Risk Hairy Cell Leukemia (HCL) Treatment with Fludarabine: Report of Three Cases with Low Toxicity and Durable Responses.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only